All Fields Required Unless Otherwise Stated
After registering, your account on the IGBB system will be ready to use. By default, you will be identified as an external user (non-MSU Employee).
If you are an MSU employee and you are interested in purchasing services from IGBB, your account type can be updated by IGBB personnel.
Topic:
Tick genomics
IGBB Scientists:
Daniel Peterson
Funding:
USDA & IGBB
Adverse outcome pathway development II: Best practices
IGBB Authors:
Natàlia Garcia-ReyeroPUBLICATION YEAR:
2014IMPACT FACTOR:
5.023CITATION COUNT:
121Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, Ottinger MA, Vergauwen L, Whelan M (2014) Adverse outcome pathway development II: Best practices.
Toxicological Sciences 142(2): 321-330.
DOI:
10.1093/toxsci/kfu200EID:
2-s2.0-84922465985PMID: 25466379
DOWNLOAD PDFABSTRACTOrganization of existing and emerging toxicological knowledge into adverse outcome pathway (AOP) descriptions can facilitate greater application of mechanistic data, including those derived through high-throughput in vitro, high content omics and imaging, and biomarker approaches, in risk-based decision making. The previously ad hoc process of AOP development is being formalized through development of internationally harmonized guidance and principles. The goal of this article was to outline the information content desired for formal AOP description and some rules of thumb and best practices intended to facilitate reuse and connectivity of elements of an AOP description in a knowledgebase and network context. For example, key events (KEs) are measurements of change in biological state that are indicative of progression of a perturbation toward a specified adverse outcome. Best practices for KE description suggest that each KE should be defined as an independent measurement made at a particular level of biological organization. The concept of "functional equivalence" can help guide both decisions about how many KEs to include in an AOP and the specificity with which they are defined. Likewise, in describing both KEs and evidence that supports a causal linkage or statistical association between them (ie, a key event relationship; KER), best practice is to build from and contribute to existing KE or KER descriptions in the AOP knowledgebase rather than creating redundant descriptions. The best practices proposed address many of the challenges and uncertainties related to AOP development and help promote a consistent and reliable, yet flexible approach. © The Author 2014.
Catherine GreshamResearch Associate III
BIOCOMPUTING
emailn/a
Texarkana, AR
The IGBB is supported, in part, by the following units:
The IGBB is an HPC² member center.
